Novo Nordisk launches weight-loss drug Wegovy in the UK market
Novo Nordisk, the Danish drug manufacturer, has launched Wegovy, a weight-loss drug, in the UK market. This semaglutide injection will be available through specialist...
Boehringer to test obesity drug in three late-stage trials
Germany's Boehringer Ingelheim said on Thursday (Aug 17) it would conduct three late-stage studies for its obesity drug candidate after it showed up to...
Weight-loss drug pioneers aim to jump on Novo Nordisk’s Wegovy bandwagon
Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for...
Amgen says experimental obesity drug has promising durability
Amgen's experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company...